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resumo 
 
 
O uso extensivo de compostos organostânicos e a sua consequente descarga 
no ambiente levou à contaminação dos ecossistemas marinhos e de água 
doce. Vários estudos mostram que estes compostos estão envolvidos no 
fenómeno conhecido como “Imposex” em gastrópodes e que podem afectar 
outros organismos, incluindo os seres humanos. É assim, de grande 
importância, a remoção destes contaminantes dos ecossistemas.  
Foi isolada e identificada uma espécie do género Aeromonas com elevada 
resistência ao tributilestanho (TBT). A estirpe, Aeromonas molluscorum Av27, 
é capaz de degradar o TBT em compostos menos tóxicos como o 
dibutilestanho (DBT) e o monobutilestanho (MBT). Foi demonstrado que nesta 
estirpe o gene sugE A. molluscorum Av27 (sugE-Av27) está implicado na 
resistência ao TBT. Este gene codifica para uma proteína homóloga à SugE, 
um membro da família das “small multidrug resistance” (SMR). Dada a 
possível aplicação de Av27 em processos de biorremediação, torna-se 
necessário aprofundar o estudo de todo o mecanismo de resistência nesta 
estirpe, bem como, optimizar o processo de avaliação da degradação do TBT 
pela estirpe Av27. O presente trabalho teve como objectivos: (i) verificar se, na 
presença de TBT, o aumento de expressão do gene sugE-Av27 se traduz num 
aumento da quantidade de proteína; (ii) clonar o gene sugE-Av27 num sistema 
de expressão em Escherichia coli, para posterior purificação da proteína; (iii) 
desenvolver e optimizar um método simples e rápido para detectar a 
degradação do TBT.  
Não foi possível identificar a proteína SugE A. molluscorum Av27 (SugE-Av27) 
nos extractos proteicos. Contudo, da análise por espectrometria de massa, 
pode-se inferir que outros genes relacionados com a síntese proteica, glicólise 
e síntese de ATP estão a ser sobrexpressos em resposta à exposição ao TBT. 
Uma enzima, D-alanina-D-alanina ligase, envolvida na síntese da parede 
celular, parece estar também a ser sobrexpressa, indicando que um dos 
mecanismos de resistência possivelmente envolverá a manutenção da 
estabilidade da parede celular. Com vista à purificação da proteína em estudo, 
o gene sugE-Av27 foi inserido no vector pET24 e clonado em E. coli BL21 
(DE3). Após quatro horas de indução com IPTG verificou-se um aumento da 
expressão da proteína SugE-Av27, por análise em Western blot.  
Na tentativa de desenvolver um método rápido para detecção de TBT em 
laboratório e sendo Micrococcus luteus sensível ao TBT, utilizou-se está 
espécie indicadora em bioensaios de degradação do TBT pela Av27. Assim, 
verificou-se que após um período de 54h a toxicidade do TBT diminuiu, sendo 
então provável que este composto esteja a ser degradado pela estirpe Av27. 
No presente trabalho iniciaram-se alguns estudos que poderão, no futuro, 
contribuir para o esclarecimento do mecanismo de resistência /degradação ao 
TBT pela estirpe Av27. Contudo, mais estudos são necessários, 
nomeadamente no que refere à análise da expressão dos genes que estão a 
ser sub- e sobre-expressos em Av27 em resposta à exposição ao TBT e ainda 
no que refere ao bioensaio para avaliar a degradação do TBT por Av27. 
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abstract 
 
The extensive use of organotin compounds and their subsequent discharge 
into the environment has led to contamination of marine and freshwater 
environments. Several studies shown that these compounds are involved in the 
phenomenon known as "imposex" in gastropods and may affect other 
organisms, including humans. It is thus of great importance, the removal of 
these contaminants in ecosystems. It was isolated species of the genus 
Aeromonas with high resistance to tributyltin (TBT). Aeromonas molluscorum 
Av27, is able to degrade TBT into less toxic compounds such as dibutyltin 
(DBT) and monobutyltin (MBT). It was demonstrated that the gene sugE A. 
molluscorum Av27 (sugE-Av27), was linked to TBT resistance in this strain. 
This gene codes a protein homologous to SugE, a member of the small 
multidrug resistance protein family (SMR). Given the possible application of 
Av27 in bioremediation, it is necessary to study the whole mechanism of 
resistance and optimize the degradation of TBT in this Av27 strain. Thus, the 
objectives of this study were: (i) verify the over-expression of SugE A. 
molluscorum Av27 (SugE-Av27) protein in Av27 in the presence of TBT; (ii) 
clone Av27-sugE gene into an Escherichia coli expression system, which will 
allow further purification of the protein for future characterization studies; (iii) 
development and optimization of a simple and rapid method to evaluate the 
TBT degradation/toxicity.  
In the protein extracts obtained it was not possible to identify the protein SugE-
Av27. However, analysis by mass spectrometry, suggested that genes related 
to protein synthesis, glycolysis and ATP synthesis are being overexpressed in 
response to TBT exposure. An enzyme, D-alanine-D-alanine ligase, involved in 
cell wall synthesis, also appears to be overexpressed. Indicating that one of the 
resistance mechanisms can be related to the maintenance of the cell wall 
stability.  
For the purification of the protein under study, the gene sugE-Av27 was 
inserted into the vector pET24 and cloned in E.coli BL21 (DE3). After four 
hours of induction with IPTG, there was an increased expression of SugE-Av27 
protein indicated by Western blot analysis.  
Micrococcus luteus was shown to be sensitive to TBT, thus can be applied as 
an indicator species in degradation bioassays of TBT by Av27. It was 
evidenced a decrease of the TBT toxicity  to M. luteus after a period of 54h, 
therefore this compound is being degraded by Av27.  
New perspectives opened up with this work in relation to TBT resistance 
mechanisms in Av27. To corroborate these results, further studies are needed 
including an analysis of the genes up- and downregulated in Av27 to TBT 
exposure and attempt some variations in the physicochemical parameters in 
the degradation bioassays.  
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Fig. 1- Application of TBT containing 
antifouling paints in boats. 
In a previous study, a bacterial strain, Aeromonas molluscorum Av27 (isolated 
from Ria de Aveiro, Portugal) was reported to be highly resistant to TBT (up to 3 mM). 
This strain showed to degrade TBT into the less toxic compounds, dibutyltin (DBT) and 
monobutyltin (MBT), and also to use  it as a carbon source (Cruz et al, 2007).  
Construction of a genomic library of Av27 strain, in Escherichia coli, revealed a 
gene involved in TBT resistance with high homology to the  sugE gene (Cruz et al, 
2010). The sugE gene encodes the SugE protein that belongs to the small multidrug 
resistance family, a lipophilic drugs transporter (Bay et al, 2008). Those results 
suggested that  the SugE A. molluscorum Av27 (SugE-Av27) protein, encoded by sugE 
A. molluscorum Av27 (sugE-Av27) gene, is probably somehow involved in the transport 
of TBT in the Av27 strain (Cruz et al, 2010). Thus, it seemed important to study the role 
and characteristics of Av27-SugE protein. 
The investigations carried by Cruz et al. (2007, 2010) suggest that Av27 can be 
potentially used in the bioremediation of TBT contaminated areas. Thus it is important 
to fully understand the mechanism of TBT resistance/degradation in this bacterium.   
 
 
1. Organotin compounds: use and legislation  
 
Some organotin compounds (OTC) 
like tributyltin (TBT) are widely used as 
fungicides, bactericides, pesticides, wood 
preservatives, PVC stabilizers, but are 
mainly used as additives in antifouling 
paints for boats (fig. 1). The extensive use 
and consequent discharge of these 
compounds into the environment, leads to 
marine and freshwater ecosystems contaminations. In fact, it has been shown that 
organotin compounds (OTC) are widespread in the environment and it is related to the 
worldwide decline of marine molluscs. The first report was the “Imposex” 
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phenomenon in Nucella lapillus, characterized by the superimposition of male sex 
characteristics into female gastropods (Antizar-Ladislao, 2008; Blaber, 1970).  
Since the 80´s when some reports demonstrated that these compounds affects 
non-targeted organisms, legislation that banned the use of TBT was applied to many 
countries (Konstantinou & Albanis, 2004). In 1982, France was the first country to ban 
the use of TBT-based antifouling paints from boats of less than 25m long (Alzieu et al, 
1989). Till 1988, most European countries, North America, United Kingdom, Australia, 
New Zealand and Hong Kong implemented the same legislation (Antizar-Ladislao, 
2008). The International Maritime Organization (IMO) adopted at 2001 a Convention 
that bans the use of TBT-based paints on ships, starting at 1 January 2003, and its total 
prohibition by 1 January 2008 (IMO, 2001). Unfortunately, only the prohibition of the 
use of these compounds will not solve the problem. TBT is already in the environment 
and will continue to be released in the environment, since there are lots of old boats 
that are painted with this antifouling paints, containing this toxic compound and, 
besides that, the legislation it is not universal. Development of new strategies to 
remove OTC from the environment is needed.    
 
 
2. Tributyltin (TBT) properties  
 
TBT is an organic compound 
characterized by the presence of covalent 
bonds between three carbon atoms and a tin 
atom (Sn4+). It belongs to a family of compounds 
derivates from tin with the general formula 
RnSnX4-n, where X is an anion and R an alkyl 
group. The nature of X will influence the 
physicochemical properties of the different 
compounds. Tributyltin chloride is the specimen 
that is normally used in experiments for analysis of the OTC toxicity (fig. 2). Normally, 
the toxicity of the OTC is influenced more by the alkyl substitutes than the anionic 
Fig. 2 - Chemical structure of 
tributyltin chloride. 
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substitute and shows less toxicity in this progression: R3SnX > R2SnX2 > R1SnX3 > RSnX4 
(Dubey & Roy, 2003).  
In the marine and freshwater ecosystems, TBT doesn´t remain for too long in 
the water column and adheres to bed sediments and organisms, due its high specific 
gravity near 1.2 kg l-1 at 20°C, a low solubility less than 10 mg l-1 at 20°C and pH 7.0, 
and a log Kow values near 3.2. The affinity of OTC for adsorption to sediments is 
positively correlated to the extent of organo-substitution on the tin, such that 
increasing adsorption is seen for monobutyltin (MBT) < dibutyltin (DBT) < TBT 
(Landmeyer et al, 2004). Once released from the antifouling paint, TBT is rapidly  
adsorbed by the organic matter composed by bacteria, algae that enters in the food 
chain and eventually will contaminate higher organisms (Antizar-Ladislao, 2008).  
 
 
3. Effects of TBT in microorganisms  
 
Organotins are high lipophilic compounds that when in contact with the biota 
adheres immediately to the cells walls and membranes. TBT is a membrane-active 
compound and in biomembranes it is known that it can act as an ionophore, thus 
modifying energy transduction processes in bacteria, chloroplasts and mitochondria 
(Cooney & Wuertz, 1989; Wuertz et al, 1991).  
The toxic effects of TBT in microorganisms are well documented and, as reviewed 
by Gadd (2000), it has been reported for all major groups (Table I). Cooney et al. (1989) 
studied the toxicity of organotin and organolead compounds in several yeasts and 
demonstrated that tributyltin had the highest toxicity level. These authors also showed 
that the toxicity of these compounds is influenced by the surrounding pH and salinity 
(Cooney et al, 1989). Supporting these findings, Laurence et al. (1989) also 
demonstrated that pH and salinity influenced the toxicity of organotins in the marine 
yeast Debaryomyces hansenii. These reports highlighted the importance of 
environmental factors in organotin toxicity (Gadd, 2000). For example, toxicity of the 
OTC is reduced in the seawater salinity levels, explained by the increase of Na+ and Cl- 
ions in the medium, which will possibly affect osmotic responses of the organisms, 
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including changes in intracellular compatible solutes and membrane composition, as 
reviewed by Gadd (2000). TBT is  also involved in growth inhibition, perturbation of the 
respiratory chain and membrane physical properties as evidenced by Martins et al. 
(2005) in two Bacillus sp. strains. In E. coli (Singh & Singh, 1985) and Legionella 
pneumophila (Soracco & Pope, 1983), TBT causes inhibition of ATPase, oxidation of 
substrates, and have effects in glycolysis and solute transport (Cooney and Wuertz 
(1989). 
 
Table I - Microbial processes affected by TBT. Adapted from Gadd (2000) 
Process affected Organism/organelle 
Respiration Bacteria 
Photosynthesis Cyanobacteria 
Nitrogen fixation Anabaena cylindrical 
Primary productivity Microalgae 
Growth Microalgae 
Energy-linked reactions E. coli 
Growth Aureobasidium pullulans 
Growth/metabolism Fungi 
Growth/metabolism Bacteria 
Photophosphorylation and ATP 
synthesis 
Chloroplasts 
H
+
-ATPase activity Neurospora crassa 
 
 
3.1. Resistance to TBT 
 
It is known and well reported that some bacteria are resistant to different TBT 
concentration levels (Dubey & Roy, 2003; Gadd, 2000). Presently, the resistance 
mechanism is not clearly understood, but it is known that resistant bacteria can: i) 
tolerate TBT due to inherent capability to transform it into less toxic compounds, such 
as dibutyltin (DBT) and monobutyltin (MBT) by a dealkylation mechanism (Table II) 
(Pain & Cooney, 1998); ii) to exclude TBT from the cell mediated by a multidrug efflux 
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pump (Jude et al, 2004); iii) can be used as a carbon source (Cruz et al, 2007; Pain & 
Cooney, 1998); iv) somehow can be bioaccumulated into the cell without breakdown 
the compound (Blair et al, 1982; Fukagawa et al, 1994) 
Mendo et al. (2003) have demonstrated that the susceptibility to TBT varies in 
bacteria according to the structure of the cell wall. It was demonstrated that TBT is less 
toxic to Gram negative bacteria, where growth is observed up to 900 ng Sn ml-1, then 
to Gram positive bacteria where, growth suppression occurs over  400 ng Sn ml-1 
(Mendo et al, 2003). As reviewed by Dubey and Roy (2003) among some of the listed 
Gram negative bacteria resistant to organotin are E. coli, Pseudomonas fluorences, P. 
aeruginosa, Proteus mirabilis, Serratia marcescens and Alicaligenes faecalis, and the 
Gram positive Staphylococcus aureus, S. epidermidis, Bacillus subtilis, Mycobacterium 
phlei and Vibrio spp. 
 
4.  TBT degradation 
 
Several studies suggest that TBT can be degraded into less toxic compounds, 
influenced by abiotic and biotic factors. TBT may, under favorable conditions, be 
degraded by successive dealkylation to produce DBT and MBT and finally inorganic tin, 
as reported by Dubey and Roy (2003) (Table II).  
Abiotic factors influencing TBT degradation include solubility, 
dissolved/suspended organic matter, pH, salinity, temperature and light which may 
affect the availability of the compound to the microorganism, thus influencing TBT 
toxicity (Dubey & Roy, 2003).  
There are some reports that demonstrated that TBT can be biodegraded by 
bacteria, fungi, cyanobacteria and seaweed in terrestrial and aquatic environment. 
Nevertheless the mechanism of biodegradation is not clearly understood and there is 
still a need to clarify the physiologic process, the levels of tolerance, the influence of 
anionic radicals and the importance of microbes in natural habitats (Antizar-Ladislao, 
2008; Dubey & Roy, 2003; Gadd, 2000). Dowson et al. (1996) demonstrated that biotic 
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factors are the most important on TBT degradation in freshwater and estuarine 
sediments.  
A recent work carried by Sakultantimetha et al. (2009) identified two new TBT 
resistant bacteria capable of biodegrading the compound. One of the isolates, 
Enterobacter cloacae, was then employed on bioremediation studies (Sakultantimetha 
et al, 2010a; Sakultantimetha et al, 2010b).   
 
 
Table II – Degradation of TBT via successive dealkylation. Adapted from Antizar-Ladislao (2008) 
Compound Chemical structure Enzyme Formula 
Tributyltin, TBT  
TBT dioxygenase 
C12H27Sn
+ 
β-hydroxybutyl-dibutyltin 
DBT dioxygenase 
C12H27OSn
+ 
Dibutyltin, DBT 
 
C8H18Sn
+ 
β-hydroxybutyl-butyltin 
MBT dioxygenase 
C18H18OSn
+ 
Monobutyltin, MBT 
 
C4H9Sn
+ 
β-hydroxybutyl 
 
C4H12OSn
+ 
Tin  
 
Sn4+ 
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5. Bioremediation of contaminated sites/environment  
 
Some microorganisms are able to degrade or accumulate a variety of organic 
compounds that exists as contaminants in the environment. This is the fundament for 
bioremediation, where the metabolic potentials of microorganisms are 
explored/enhanced in order to optimize the decontamination of a given environment 
(Megharaj et al; Perelo, 2010).  
The major benefit of bioremediation is the low cost relatively to 
physicochemical strategies, and in addition, it is a non-invasive and permanent 
technique leaving the ecosystem intact. Bioremediation also presents advantage when 
applied at contaminated sites with low toxic concentration, which would be 
impracticable when conventional remediation techniques are applied. Although, 
bioremediation has some drawbacks that can limit its application, as for instance,   
taking longer and being less predictable than conventional methods (Perelo, 2010).  
Strategies for bioremediation include: (i) monitored natural recovery (MNR): 
some places have natural occurring chemical and physical process which associated 
with the microflora biodegradation leads to “self-remediation”; (ii) biostimulation: 
addition of key nutrients and manipulation of abiotic factors (e.g.: pH, temperature) 
that will enhance the biodegradation of the contaminants; (iii) bioaugmentation: 
introduction of appropriate species that show skills to degrade the contaminant; (iv) 
phytoremediation: use of plants or algae in the degradation and/or removal of 
contaminants from the environment (Megharaj et al; Perelo, 2010). 
 
5.1. Use of microorganisms for bioremediation 
 
The development of genetically engineered microorganisms (GEM) is an 
important tool to develop new strategies for remediation and monitoring of 
contaminated sites.  Modification of enzymes, pathway construction and regulation, 
bioprocess development, monitoring and control, and biosensor development are the 
major approaches for the application of GEM in bioremediation. In table III  are shown 
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some examples of GEM that have great degradation capacity and some that have been 
applied in bioremediation (Menn et al, 2008).   
It is of great importance to monitor contaminated environments, either by 
determining the content/concentration of the toxic compounds or to assess the 
modifications of microbial populations. Molecular biology had brought new insights 
into bioremediation, mainly in bioaugumentation since it allowed the identification 
and characterization of the microbial population without cultivation, important when 
exogenous strains are added, given more consistent results in monitoring (Sayler & 
Ripp, 2000; Watanabe, 2001). 
Biosensors to monitor contaminated sites are being adopted as suitable 
alternatives or complementary analytical tools in current days. As this emerging 
technology offers great advantages when compared with the conventional analytical 
tools, biosensors are able to identify and quantify specific compounds, with high 
sensitivity and accuracy (Durand et al, 2003; Rodriguez-Mozaz et al, 2005). 
Nevertheless research is still needed to improve them. It is in this wide aim that the 
present work is focused. A. molluscorum Av27 was reported to be highly resistant to 
TBT and also has having the ability to degrade it (Cruz et al, 2007). Thus Av27 can be 
potentially improved as a tool for TBT decontamination (Cruz et al, 2010) and 
therefore, studies are in progress to achieve this aim. Hence, it is of major importance 
to understand all the pathways that are involved in the TBT resistance/degradation 
ability exhibited by this strain.  
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Table III – GEM applied in biodegradation of contaminants and in biodegradation process efficacy.   
BTEX - benzene, toluene, ethylbenzene, and xylene; 2,4-D - 2,4-dichlorophenoxyacetic acid; PBC - 
polychlorinated biphenyls; TCE – trichloroethylene. Adapted from Menn et al. (2008) 
Microorganism Modification/Application Contaminant 
Pseudomonas sp. B13 pathway mono/dichlorobenzoates 
P. putida pathway 4-ethylbenzoate 
P. putida KT2442 pathway toluene/benzoate 
Pseudomonas sp. FR1 pathway chloro-, methylbenzoates 
C. testosteroni VP44 substrate  specificity o-, p-monochlorobiphenyls 
Pseudomonas sp. LB400 substrate  specificity PCB 
E. coli JM109 (pSHF1003) substrate  specificity PCB, benzene, toluene 
P. pseudoalcaligenes KF707-D2 substrate  specificity TCE, toluene, benzene 
E. coli FM5/pKY287 regulation TCE, toluene 
A. eutrophus H850Lr process monitoring PCB 
P. putida TVA8 process monitoring TCE, BTEX 
P. fluorescens HK44 process monitoring naphthalene, anthracene, 
phenanthrene 
B. cepacia BRI6001L strain monitoring 2,4-D 
P. fluorescens 10586s/pUCD607 stress response BTEX 
P. fluorescens 10586s/pUCD607 toxicity assessment chlorobenzenes, chlorophenols, 
BTEX 
Pseudomonas strain Shk1 toxicity assessment Cd, 2,4-dinitrophenol, 
hydroquinone 
A. eutrophus 2050 end point analysis nonpolar narcotics 
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6. A multidrug transporter family - Small multidrug resistance proteins 
 
Small multidrug resistance proteins (SMR) comprehend a family of small 
integral inner membrane proteins, with approximately 12kDa and 100 to 140 amino 
acids in length (Paulsen et al, 1996b). The SMR protein family belongs to the 
drug/metabolite transporter (DMT) superfamily (Jack et al, 2001; Putman et al, 2000; 
Saier & Paulsen, 2001; Saier, 2000).  
SMR proteins family confers resistance and has only been reported to transport 
quaternary ammonium compounds (QAC), other lipophilic cations and may also 
transport a variety of antibiotics (Bay et al, 2008; Heir et al, 1999; Jack et al, 2000). Its 
structure is characterized by four transmembrane (TM) α-helices domains with short 
hydrophilic loops, turning SMR highly hydrophobic, making them solubilized in organic 
solvents (Yerushalmi et al, 1995; Yerushalmi et al, 1996). It has also been reported that 
the transport is mediated via electrochemical proton gradient force (Paulsen et al, 
1996a; Paulsen et al, 1996b; Yerushalmi et al, 1995), and therefore classified as 
proton-dependent multidrug efflux system (Paulsen et al, 1996a). 
Once not all the proteins in the SMR family demonstrate drug efflux, in the 
beginning, the SMR family was divided into two distinct classes: i) small multidrug 
pumps (SMP) and ii) suppressor of groEL mutation proteins (SUG). This division was 
supported by the phenotype that they confer (Greener et al, 1993; Saier et al, 1998) 
and by the phylogenetic assessments (Chung & Saier Jr., 2001; Paulsen et al, 1996b).   
Multidrug efflux pumps were identified and characterized, and seem to have 
homology with SMR proteins. These homologues are distinct from the other two 
groups of SMR proteins, once it is necessary the co-expression of two separate SMR 
genes within the host to demonstrate the same resistance profile of SMP and SUG 
(Chung & Saier Jr., 2001). An example of this paired SMR proteins are Bacillus subtilis 
EbrA and EbrB (Masaoka et al, 2000), YkkC and YkkD (Jack et al, 2000).  Also, Bay et al. 
(2008) proposed that this family is divided in three subclasses: the small multidrug 
protein (SMP), the suppressor of groEL mutation protein (SUG) and paired SMR 
(PSMR). 
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Fig. 3 - Lipophilic cations used in the Sikora 
and Turner (2005a) experiments. 
6.1. SMP subclass 
 
The ethidium multidrug resistance protein (EmrE) from Escherichia coli is 
considered the representative model of the SMR family, and belongs to the SMP 
subclass, being the best known and well characterized protein from this family 
(Schuldiner et al, 2001). Previously named as mvrC, the emrE gene was first identified 
and cloned from the genome of E. coli, regarding its resistance to ethidium bromide 
(Purewal, 1991) and to methyl viologen (Morimyo et al, 1992).  
It has been demonstrated that two types of residues in multidrug resistance 
proteins are involved in binding to QAC. A negatively charged residue binds to the 
positive charge of the ligand, highly conserved in the multidrug resistant proteins 
(Muth & Schuldiner, 2000; Paulsen et al, 1996b). In EmrE, a glutamate residue located 
in the first TM helix is present for this purpose (Muth & Schuldiner, 2000). Also 
aromatic residues are important in the protein-drug interaction; they are involved in 
Van der Waals forces and π-π interactions with the aromatic rings of the ligand 
(Dougherty, 1996; Zhong et al, 1998). EmrE contain the residues Y40, Y53, F44 and Y60 
and W63 that may play a role in the interaction protein/ligand. Reports demonstrated 
that when some of these residues are mutated in EmrE, the protein is non-functional 
(Elbaz et al, 2005; Mordoch et al, 1999; Yerushalmi & Schuldiner, 2000a). 
Sikora and Turner (2005a) used 
isothermal titration calorimetry (ITC) to 
monitor the binding of some lipophilic 
cations (fig. 3) to EmrE in different 
membrane mimetic environments, thus 
providing information about the 
stoichiometry and thermodynamic 
properties of protein-ligand interactions. 
The binding stoichiometry of EmrE to 
drug was found to be 1:1 (mol/mol), 
indicating that oligomerization of EmrE is 
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not necessary for binding the drug. Nevertheless, the oligomerization is necessary for 
the transport of the drug across the cell membrane, once another EmrE subunit is 
required to bind protons necessary for the transport mediated via electrochemical 
proton gradient force (Muth & Schuldiner, 2000; Yerushalmi & Schuldiner, 2000a; 
Yerushalmi & Schuldiner, 2000b). Indeed, Bay et al. (2010) showed that the multimeric 
forms of EmrE are influenced by the concentration of SDS and it is stabilized by the 
ligand in the mimetic environment, demonstrating that EmrE is capable of multimeric 
flexibility, altering its subunit amount to correspond to ligands.   
 
6.2. SUG subclass 
 
One of the genes that seem to be involved in the TBT resistance by Av27, is a 
homologue of the sugE gene, and encode a protein designated SugE-Av27. Thus this 
last is probably a member of the SUG subclass of the SMR family.  
SUG subclass is poorly studied and understood. SugE was firstly described and 
identified as a suppressor of a groEL mutation and in addition it could mimic the effect 
of GroEL over-expression in a Klebsiella pneumoniae (Greener et al, 1993). GroEL, 
homologous to Hsp60 (eukaryotic heat shock protein), is part of the GroEL/GroES 
chaperone complex within bacteria. Chaperones helps in the proper folding of proteins 
in natural conditions, as also in cellular damage by heat shock or others stress 
conditions (Georgopoulos, 2006). Afterwards SugE was included in the SMR family 
since its sequence showed high homology with others SMR proteins, like EmrE (Bay et 
al, 2008; Chung & Saier Jr., 2001). In E. coli, SugE and EmrE share 27% sequence 
identity and 52% sequence similarity (Sikora & Turner, 2005b). However, SugE is not 
capable to recognize or transport the diverse QAC and lipophilic dyes demonstrated by 
SMP proteins (Chung & Saier, 2002). SugE confers resistance phenotype to a narrow 
range of compounds, mostly to antiseptics, with acyl chains covalently bound to a 
single N cation, like cetylpyridinium, cetyldimethylethyl ammonium and 
hexadecyltrimethyl ammonium (Chung & Saier, 2002). 
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Mutagenesis assays carried by Son et al. (2003) showed that when key residues 
of SugE, equivalent to those preserved in the SMP subclass, were mutated (fig. 4), the 
clones would became hypersensitive to all drugs tested. This report shows that SugE is 
functioning as a drug importer (Son et al, 2003). The orientation in the membrane of 
both SugE and EmrE was determined to be N- and C- terminal in the cytoplasm side of 
the inner membrane; this exclude that the orientation of SugE was the cause of the 
importer activity (Son et al, 2003). When the histidine-24 (conserved in the SUGs) is 
exchanged for glutamate (conserved in the SMPs), there is an exchange from a 
positively charged residue to a negatively charged residue, leading to a hypersensitivity 
to the more positively charged compounds (Son et al, 2003). In the SMP protein QacC 
from Staphylococcus aureus, the mutation of Glu-24 demonstrated that this residues is 
involved in determining the specificity of drug resistance (Grinius & Goldberg, 1994). 
These evidences and another experiments with EmrE (Edgar & Bibi, 1997; Grinius & 
Goldberg, 1994; Heldwein & Brennan, 2001; Muth & Schuldiner, 2000; Paulsen et al, 
1996b) reveals that these conserved residues in SugE and EmrE are involved in drug 
binding to the protein.   
Sikora and Turner (2005b) have demonstrated that SugE and EmrE have similar 
affinity and stoichiometry to drugs. Like EmrE (Sikora & Turner, 2005a), SugE shows to 
bind to drugs in a ratio 1:1 (one drug bind to one SugE subunit) with similar strength 
(Sikora & Turner, 2005b). Sikora and Turner (2005a; 2005b) have postulated too, that 
the drugs initially has a weak binding into the membrane, and therefore, once it is 
energetically favorable, the drug enters into the binding pocket of SugE.  
The conformation of SugE  has never been confirmed and explored, till a recent 
study carried by Bay and Turner (2011). It was reported that SugE protein appears like 
a monomer in Tricine SDS-PAGE, when independently solubilized in two detergents, 
sodium dodecyl sulphate (SDS) and dodecyl maltoside (DDM). However, SugE appears 
as a dimer at higher protein concentration in SDS (Bay & Turner, 2011).  
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Fig. 4 - Schematic representation of E. coli SugE and EmrE showing their sequence and topology. The 
residues in blue are the ones that were mutated to convert a SugE into an EmrE. Residues that are 
conserved in all members of the SMR family are in red. The green residues are the SMR similar 
motifs (Son et al, 2003). 
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Contrary to what is observed  with EmrE, multimerization of SugE didn’t seem 
to be influenced by increasing QAC : protein molar ratio, although, the electrophoretic 
mobility is altered (Bay & Turner, 2011).  
It was demonstrated that EmrE and SugE proteins are quite similar. Both have 
transmembrane α-helix content, the tertiary conformation can be altered by the 
environment (ratio of drug:protein, detergent) and also SugE and EmrE have conserved 
residues at similar positions, that are responsible for recognizing and binding the drug 
with similar stoichiometry and strength.  Only the events that take place after binding 
are different; just EmrE shows resistance to all drugs tested (fig. 4) (Sikora & Turner, 
2005b). Further studies are still needed to better clarify the function and the mode of 
action of these SUG proteins.  
 
7. Methodological approaches  
 
TBT resistance by Av27 strain is known to be linked to the relative over-
expression of the sugE-Av27 gene (Cruz et al, 2010). SugE protein belongs to the SUG 
subclass of the SMR proteins family and little is known about this subclass (Bay et al, 
2008). Thus it is crucial to understand how the SugE-Av27 protein works and how is it 
involved in the TBT resistance in Av27. To that end, purification of this protein is 
needed. 
Not all the proteins are naturally present in an aqueous phase; actually, in 
prokaryotes, there are cell membrane proteins and in Gram-negative bacteria, 
periplasmic proteins that are partly immobilized between the outer and inner 
membranes of the cell. For their isolation and purification special needs must be 
considered and in each case analyzed individually (Scopes, 1993). 
 The membrane proteins can be divided in two different types, peripheral or 
integral. If we are dealing with a peripheral membrane protein, they can be easily 
isolated by easygoing treatments that do not involve solubilization of the membrane. 
On the other hand, with integral membrane proteins special conditions are needed, 
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once they are embedded within and often right across the membrane, which isolation 
and purification will almost always need a solubilization step of the membrane 
(Scopes, 1993).         
 From the previous studies of the gene sugE-Av27, and the predicted aa 
sequence of the protein, it is expected that the SugE-Av27 protein is an integral 
membrane protein from the inner membrane of Av27 strain (data not published). For 
the isolation of this protein isolation and solubilization of the inner membrane is 
needed. The addition of the Triton X-114 detergent to the extraction protocol, as the 
one described by Arnold and Linke (2008), will help to achieve this purpose (fig. 5).  
 
 
 
Fig. 5 - Mode of action of the detergent on biomembranes. Detergents insert into the bilayer (A and 
B), and at high concentrations form mixed micelles with lipids and membrane proteins, keeping the 
proteins soluble (C) (Arnold & Linke, 2008). 
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Fig. 6 - MALDI-TOF/TOF analyser 
In the present work, mass spectrometry analysis was the technique selected, to 
detect and identify SugE-Av27 protein in the membrane protein extract of Av27 strain. 
Mass spectrometry is an analytic technique that measures the masses of individual 
molecules, often referred as analytes, which are first ionized and separated according 
to its mass-to-charge ratios (m/z). The protein sample is digested into smaller 
peptides, which are characterized by mass measurements or sequence ions analysis. 
Using the appropriate software, comparing to proteins from the database, a probable 
identification is obtained (Dass, 2001; Westermeier & Naven, 2002).  
The mass spectrometer can be divided into three different parts, which involve 
the three basic steps in mass spectrometry:  
 
 the ion source: where the molecular ions are produced. Ionization 
converts the analyte molecules into gas-phase ionic species, by the 
removal or addition of electrons or protons; 
 the analyzer: where the molecular ions and their charged fragments are 
separated and analyzed on the basis of their m/z ratios; 
 the detector: where ions are detected. The mass-separated ions are 
measured, amplified and displayed through software in the form of a 
mass spectrum. 
 
MALDI-TOF is a well established mass 
spectrometry technique which has proved its 
abilities for identifying proteins, peptides and some 
other ionisable compounds in samples. The 
association of MALDI source to a TOF analyzer (fig. 6) 
enables the analysis of larger biomolecules avoiding 
its breakdown and degradation by the temperature 
elevation triggered by laser incidence (Constans, 
2005). 
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In order to characterize a protein, it is necessary to get it pure and in high 
amounts. Purification of the protein directly from the host strain could be difficult; also 
obtaining high concentrations of the protein might also be difficult. Since normally 
there are only a few molecules per cell. Thus, recombinant DNA technology seems to 
be the solution to overcome this problem (Maloy et al, 1994). 
Heterologous expression in a host strain such as E. coli, with the selected 
expression vector pET24 (fig. 7), could allow the production of the target protein with 
a histidine-tag (his-tag). The protein, SugE-Av27_his-tag, can be easily detected with 
specific antibody anti-his-tag in a Western blot analysis. Also, it is possible to 
determine the best conditions for maximum expression of the protein. Furthermore, 
the purification of the protein will be easily achieved by immobilized metal ion affinity 
chromatography (IMAC) with Ni+ that has high affinity to his-tag (Terpe, 2003). 
 
 
 
 
 
 
 
Fig. 7 – pET24 vector cloning/expression region (NOVAGEN). Red square indicates the region in the vector 
which encodes the his-tag; green squares indicates the restriction sites where was inserted the sugE-Av27 
gene; rbs - ribosome binding site. 
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Gas chromatography - mass spectrometry (GC-MS) is one of the analytic 
techniques that is normally employed to analyze the content of organotin compounds 
in environmental and laboratorial samples (Antizar-Ladislao, 2008). This technique is 
expensive and time consuming. Optimization of one simple and rapid method to 
detect the degradation/content of TBT/organotins prior to send samples for analysis, 
in laboratorial assays will be a time/cost benefit to the development of a study.   
Micrococcus luteus is known to be an indicator specie in many toxicological 
assays (Caetano, 2011). In the present work, the use of this indicator specie to indicate 
TBT degradation will be evaluated. 
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TBT contamination in the environment is a worldwide problem. Screening for 
microorganisms resistant to this compound allowed the isolation of Aeromonas 
molluscorum Av27, a Gram negative bacterium highly resistant to TBT that shows the 
ability to degrade it into its less toxic products: DBT and MBT. Genomic studies with 
Av27 strain revealed the presence of the gene sugE-Av27 that encodes an inner 
membrane protein involved in the resistance mechanism. This protein belongs to the 
SMR protein family. Understanding how this protein is involved in the resistance to 
TBT and also evaluating the TBT degradation capacity by Av27 are the main goals of 
this work.  
 
With that purpose the following aims were addressed: 
 
i) Verify the over-expression of SugE-Av27 protein in Av27 in the 
presence of TBT ; 
ii) Clone sugE-Av27 gene into an E. coli expression system, which 
will allow further purification of the protein for future 
characterization studies; 
iii) Development and optimization of a simple and rapid method to 
evaluate the TBT degradation/toxicity.  
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1. Extraction of SugE protein from Av27 
 
1.1. Protocol 1  
 
Av27 was grown at 26°C at 160rpm in a 500ml sterile Erlenmeyer flask, in two 
conditions: (i) 100ml of TSB medium (MERCK) without TBT; and (ii) 100ml TSB medium 
(MERCK) containing 500µM TBT; both conditions were made in dark to avoid 
photochemical degradation of TBT. Once achieved an O.D.600 nm ≈ 0.2, the culture was 
harvested by centrifugation at 4000g for 10min and the cellular pellet was stored at -
20°C. 
Extraction of membrane proteins was achieved with an adaptation of the 
protocol from Arnold and Linke (2008). Cellular pellet was resuspended in 500µL of 1x 
phosphate buffered saline (PBS) (VWR International Ltd.). The suspension was 
centrifuged at 13000 g for 1 min (this two first steps were repeated twice). The pellet 
obtained was then solubilized in 400 µL of solubilization solution (10mM Tris-HCl pH 
7.4, 150mM NaCl, 1% (v/v) Triton X-114), incubated 10min at 4°C and centrifuged at 
12000g for 30s at 4°C. To the solubilized culture (top), a sucrose solution (10mM Tris-
HCl pH 7.4, 150mM NaCl, 0.06% (v/v) Triton X-114, 6% (w/v) sucrose) was added 
carefully and incubated for 10min at 37°C. A centrifuging step at 12000g for 5min at 
4°C separated the solution in two phases. The aqueous phase (top) and detergent 
phase (“oil” in the bottom) was recovered into a new and clean eppendorf. Triton X-
114 was added to the aqueous phase at a final concentration of 2% (v/v) and the 
separation step was repeated. 100µL of 10mM Tris-HCl pH 7.4, 150mM NaCl Buffer 
was added to the detergent phase. Finally 10 volumes of ice-cold acetone (-20°C) was 
added to each final samples and leaved overnight at 4°C. To recover the precipitated 
protein was centrifuged at 12000g for 20min at 4°C. The pellet was then resuspended 
in 100µL of 10mM Tris-HCl pH 7.4, 150mM NaCl Buffer.   
 
 
Material and Methods 
 
  Rafael Mascaretti Moreira                                                                                                                     30 
 
1.2. Protocol 2 
 
Since with the previous protocol, it was not possible to detect the SugE-Av27 
protein by MS analysis (see results and discussion section), another protocol was 
attempted that consisted in an adaptation of the one from Winstone et al. (2002). 
Av27 cells were grown at 26°C at 160rpm in a 5L sterile Erlenmeyer flask, in two 
conditions: (i) 1L of TSB medium (MERCK) without TBT and (ii) 1L of TSB medium 
(MERCK) containing 500µM TBT; both conditions were made in dark to avoid 
photochemical degradation of TBT. Once achieved an O.D.600 nm ≈ 0.2, cultures were 
harvested by centrifugation at 4000g for 10min and the cellular pellet was stored at -
20°C.  
Frozen Av27 cell pellets were thawed at 4°C and resuspended in 2ml of SMR A 
buffer (50mM MOPS, 5mM EDTA, 1mM DTT, 8% v/v glycerol, pH=7.5) per gram of cell 
mass. 1µL of 10mM phenylmethanesulfonylfluoride (PMSF) was added per milliliter of 
cell suspension immediately prior to sonication (10s, 5x, spaced by 10s). After 
sonication the low speed pellet (LSP) or unbroken cell debris was collected by 
centrifugation at 9000g for 15min and the supernatant was centrifuged at 110,000g for 
1h30min to collect the membrane pellet. The supernatant (cytosol) fraction was 
removed and the membrane pellet was resuspended in SMR A buffer till complete 
solubilization. This membrane suspension was then frozen in aliquots and stored at -
80°C prior to further processing  
 
1.3. Determination of protein concentration 
 
Protein concentration of the extracts was determined using the Qubit™ Protein 
Assay Kits from Invitrogen.  
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1.4. Sodium dodecyl sulfate - polyacrylamide gel electrophoresis (SDS-
PAGE) 
 
Protein samples were analyzed on a Bio-Rad Mini-PROTEAN Tetra Cell 
apparatus using a 6% acrylamide stacking gel, 18% and 20% acrylamide separating gel 
(Appendix 1). Protein samples were solubilized in SDS–PAGE loading buffer (125 mM 
Tris, 4% w/v SDS, 20% w/v glycerol, 0.0025% w/v bromophenol blue and 2.5% beta-
mercaptoethanol, pH 6.8) at proportions 1:1, for 5 min at 95°C prior for loading. Gels 
were stained with coomassie blue stain (0.1% w/v coomassie R250, 50% v/v metanol, 
10% v/v acetic acid) overnight and de-stained with 15% v/v methanol, 10% v/v acetic 
acid for a minimum of 3h (Laemmli, 1970).  
Tricine SDS-PAGE were prepared as described above with the exception that 
16% acrylamide separating gels were made (Appendix 1). The anode buffer was made 
to contain 0.2M Tris, pH 8.9 while the cathode buffer containing 0.1M tricine in 
addition to 0.1M Tris and 0.1% w/v SDS, pH 8.25. Tricine SDS-PAGE samples were 
processed identically to SDS-PAGE samples and were also run, stained and destained 
identically to SDS-PAGE. 
 
1.5. Mass spectrometry analysis  
 
For the proteins identification, the bands presented in the SDS-PAGE were 
excised and were added 20µl of ammonia bicarbonate 10% and left to incubate for 30 
min, then added 20µl of acetonitrile (ACN) and left for more 30min. The bands were 
decanted and the two previous steps repeated twice (when performed a Tricine SDS-
PAGE the steps were repeated 4 times). The samples were then evaporated on a 
SpeedVac. Once dried, 25µl of 10µg/ml trypsin in 50mM ammonium bicarbonate was 
added to the sample and left at 37°C overnight. The tryptic peptides were extracted 
from the gel with formic acid and were then dried in vacuum and resuspended in 10μl 
of a 50% acetonitrile/0.1% formic acid solution. 
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The full extracts (protocol 1 and 2) were incubated with trypsin and the tryptic 
digests were separated using an Ultimate 3000 (Dionex/LC Packings, Sunnyvale, CA). 
Ten microlitres of each sample (corresponding to 1µg of protein) were injected onto a 
C18 trapping column (Pepmap300, 5um particle size, 5mm, Agilent Technologies) using 
an autosampler (Dionex/LC Packings). The sample was washed over the trapping 
column for 5 min with 95% buffer A (water, 0.1% TFA), 5% buffer B (ACN, 0.05% TFA) 
at a flow rate of 300 nl/min. Afterwards, the sample was eluted onto a 150 mm x 75 
µm PepMap100 capillary analytical C18 column with 3mm particle size (Dionex/LC 
Packings) at a flow rate of 300 nl/min. A linear gradient of 5–50% buffer B was run over 
a period of 35min. The separation was monitored at 214nm using a UV detector 
(Dionex/LC Packings) equipped with a 3nl flow cell. The peptides eluting off the C18 
capillary column were directly mixed with α-CHCA matrix solution (2mg/ml in 70% 
ACN/0.3% TFA) containing internal standard Glu-Fib (15 ftmol for MALDI-TOF/TOF MS 
analysis) under a continuous flow rate of 270nl/min. The fractions were then 
deposited onto the LC-MALDI plates at 20s intervals for each spot (100 nl/fraction), 
starting 5min after the beginning of the separation process, using the Probot 
(Dionex/LC Packings).  
The MALDI-TOF/TOF MS analysis of the samples was performed using a 4800 
MALDI-TOF/TOF Analyzer (Applied Biosystems, Foster City, CA). Screening of the LC-
MALDI plate was performed in the MS positive reflector mode using 1200 laser shots 
and TOF-TOF MS analysis of automatically selected precursors was performed at a 
collision energy of 2kV using air as collision gas at a pressure of 2 x 10–7torr. MS spectra 
were internally calibrated using Glu-Fib and several trypsin autolysis products. Up to 
ten of the most intense ion signals per spot position with S/N ratio above 50 were 
selected as precursors for MS/MS. 
The spectra were processed and analysed by the Global Protein Server 
Workstation (Applied Biosystems), which uses internal MASCOT software (v.2.1.0.4, 
Matrix Science, UK) for protein/peptide identification based on the peptide mass 
fingerprints and MS/MS data. The search was performed against the Swiss-Prot 
protein database. MS tolerance of 30ppm for precursor ions and 0.3Da for fragment 
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ions, two missed cleavages and carboxymethylation of cysteines were selected for 
protein identification. Protein identification was accepted as positive when both the 
MASCOT total ion scores for a given protein and its best peptide individual score 
exhibit confidence intervals higher than 97%.  
 
2. Expression of SugE protein in Escherichia coli  
 
To get full amounts of SugE-Av27 protein to fully characterization, it was done 
heterologous expression in E. coli system with his-tag for forward purification with 
IMAC technique.      
Three different clones were made, one with the sugE-Av27 gene attached to 
the his-tag (clone BL21_sugE_HT), one with the sugE-Av27 gene without a tag (clone 
BL21_sugE_STOP) and another one only with the original vector (clone BL21_pET24). 
These two last ones were made for controls in the induction and purification protocols.   
 
2.1. Amplification of the target gene 
 
Specific primers were designed to amplify the target gene and containing, at 
each terminal, the NdeI or XhoI restriction sites (Appendix 2), allowing ligation into the 
NdeI/XhoI pET24 vector (fig. 7, Introduction section). The PCR amplification was made 
with Thermo Scientific Taq and buffers. The PCR reaction protocol was 50µL of Master 
Mix, 3µL of forward primer and reverse primer, 42µl of dH2O and finally 2µL of Av27’s 
cells suspension. The PCR protocol and program can be seen in the Appendix 2. After 
the amplification, the PCR product was purified with the Jetquick PCR Product 
Purification kit from GENOMED. 
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2.2. Digestion and ligation of pET24 vector and PCR product 
 
The vector pET24a(+) (NOVAGEN) was extracted from the E. coli DH5α_pET24 
by QIAprep® Spin Miniprep Kit (QIAGEN). The pET24 and PCR products digestions were 
made with the restriction enzymes NdeI, XhoI and respective buffer from FERMENTAS. 
The reaction mixture can be viewed at the table IV; the incubation was made at 37°C 
for 3h. 
 
 
 
 pET24 PCR product 
DNA 20 µL 10 µL 
XhoI (10 U/µl) 4 µL 4 µL 
NdeI (10 U/µl) 2 µL 2 µL 
Orange buffer (10X) 4 µL 4 µL 
dH2O 10 µL 20 µL 
  
 
Once the digestion was completed the digested inserts and plasmid were 
purified with the Jetquick PCR Product Purification kit from GENOMED. The 
concentration of DNA was measured using the Qubit™ dsDNA HS Assay Kits. 
For the ligation of each insert to the pET24 vector was made independently the 
following reaction: 1 µL of pDNA (52 ng), 3 µL of Insert (84 ng), 2 µL Buffer (10x), 13 µL 
of d H2O and 1 µL of T4 DNA ligase enzyme (5 U/µl) from FERMENTAS. The reaction 
mixture was incubated at room temperature (± 24°C) for 1h.  
 
 
 
 
Table IV – Reaction mixture for the digestion of the 
pET24 vector and the PCR product. 
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2.3. Preparation of competent E. coli BL21 cells 
 
E. coli BL21 (DE3) cells glycerol was stored at -80°C. A pre-inoculum was made 
with an aliquot from the glycerol, and then 1ml added to 50ml LB medium containing 
15µg/ml tetracycline and incubated till a DO600 ≈ 0.4-0.6. The cell suspension was 
centrifuged at 7000g for 5min. The pellet was washed with 25ml of MgCl2, and once 
again, centrifuged and washed with 25ml of CaCl2 letting to incubate for 20min at 4°C. 
The washed cells were centrifuged at 7000g for 1min and the pellet resuspended in 1.5 
ml CaCl2, glycerol buffer. The full competent cells were divided in aliquots of 50 µl and 
stored at - 80°C. 
 
 
2.4. Transformation of competent E. coli BL21  
 
For the transformation, 5µl of each pDNA (pET24_sugE_HT, pET24_sugE_STOP 
and pET24) independently, was added to 50µl of BL21 competent cells and left on ice 
for 15min, then transferred to 42°C dry bath for 45 sec and right away again in ice for 
2min. Finally, added 1ml of LB medium without antibiotic and incubated at 37°C 
160rpm for 1h. The cell suspension was centrifuged at 5000g for 1min and the pellet 
decanted and resuspended in the remaining medium. Cells were then plated in LB 
plates containing 50µg/ml of kanamycin (Kan) and left at 37°C overnight. 
 
 
2.5. Screening of positive clones 
 
For the selection of positives clones, 10 colonies of each transformation were 
randomly selected and analysed by colony PCR. The program and primers are listed in 
table 2.2 (Appendix 2). 
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To verify correct constructions of the plasmid in selected positive clones, colony 
PCR was performed with the appropriate primers T7prom and T7ter (Appendix 2). The 
PCR products were sent to STABVIDA for nucleotide sequencing.  
 
 
2.6. Growth and induction of BL21 clones with IPTG 
 
A single colony of each clone was selected and inoculated in 1ml LB containing 
50µg/ml Kan, then incubated with shaking at 37°C until an OD600 ≈ 0.6. The cultures 
were stored at 4°C overnight. In the following morning, the cells were collected by 
centrifugation and resuspended in 1.5ml of fresh medium containing antibiotic. 
Incubation was made at 37°C with shaking at 250rpm till an OD600 ≈ 0.5. These 1.5ml 
cultures were used to inoculate independently 50ml LB with Kan in 250ml Erlenmeyer 
flasks. The cultures were incubated at 37°C with shaking at 250rpm until the OD was 
around 0.5-1.0. The 50ml cultures were divided into two 25ml cultures and 500µl IPTG 
(stock of 50mM) was added to one of the 25ml cultures and the other one was left as 
an uninduced control. The OD monitoring during growth was made by removing 
aliquots aseptically.   
The induced and uninduced cultures were left at 37°C with shaking at 180rpm, 
100µl samples were aseptically taken over 1, 2, 3, and 4 hours and the cells collected 
by centrifugation at 12000g for 1min. The cellular pellets were then stored at -20°C for 
prior analysis.  
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2.7. SDS-PAGE and Western blot analysis 
  
The cell samples from each time and induction were prepared to SDS-PAGE like 
described in section 1.4 from Material and Methods. 
For the Western blot, 3MM blotter paper was cut to fit the transfer cassette 
and a nitrocellulose membrane of the gel size was also cut. The gel was removed from 
the electrophoretic device and the stacking gel discarded. The transfer sandwich was 
assembled under transfer buffer (25mM tris, 192mM glycine, 10% methanol) to avoid 
air bubbles and placed in the transfer device of Bio-Rad Mini-PROTEAN Tetra Cell 
apparatus and filled with transfer buffer and left to transfer for 2h at 200mA. Once 
finished, the membrane was removed carefully and soaked in TBST (10mM Tris-HCl, 
150mM NaCl, 0.05% Tween, pH 8.0); the membrane was then blocked in 5% milk in 
TBST for 1h.  
ECLTM is a light emitting non-radioactive method for the detection of 
immobilised antigens. The membrane was incubated with 5ml of the primary anti-body 
(his-tag monoclonal antibody from mouse, NOVAGEN) diluted (1:1000) in 3% low fat 
milk in TBST for 1h at room temperature and then overnight at 4°C. In the other day 
the membrane was decanted and washed three times with TBST for 10min. 5 ml of 
secondary antibody anti-mouse diluted (1:5000) in 3% low fat milk, was added and 
incubated for 2h at room temperature, with shaking. For the detection and revelation, 
all the next steps were made in a darkroom. The membrane was incubated for 1 min 
with 1ml of the ECL detection solution (a mixture of equal volumes of solution 1 and 
solution 2 from the ECL kit (Amersham), approximately 0.125ml/cm2 membrane). 
Forward the membrane was wrapped in cling-film, taking care to eliminate all the air 
bubbles, and placed in a film cassette with an autoradiography film (XAR-5 film, 
KODAK) on top and exposed overnight. The film was developed in developing solution, 
washed in water and fixed in fixating solution. 
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3. Development of one simple and rapid method to monitor the TBT 
degradation/toxicity 
 
3.1. Evaluation of M. luteus as an indicator specie for TBT degradation 
monitoring 
 
Since M. luteus is sensible to a large variety of compounds, this microorganism 
is broadly used as indicator specie. Finding out about the sensibility of this 
microorganism to TBT and DBT, will open the possibility to use M. luteus as indicator 
specie, to evaluate the degradation of TBT by A. molluscorum Av27 in liquid assays.  
The sensitivity of M. luteus to TBT and DBT was tested using different 
concentration of these compounds (25µM, 50µM, 100µM) in TSB plates (MERCK). Each 
assay was made in duplicate, one incubated at 37°C (optimal temperature for M. 
luteus) and another one divided in two parts, where Av27 and M. luteus were 
inoculated and incubated at 30°C (temperature that both microorganisms grow). In 
each case, control without TBT was made. 
 
3.2. Optimization of the bioassay method to evaluate TBT 
degradation/toxicity 
 
A liquid assay was made for the degradation of TBT experiment. Av27 was 
inoculated with 25µM of TBT in 100mL of Marine broth (MB) (DIFCO) and left 
incubating over time at 26°C, 150rpm. To monitor any potential photo- and chemical 
natural degradation of TBT, a control with 25µM TBT in 100mL of MB (DIFCO) was 
made and incubated under the same conditions. Aliquots of 100µL of these two 
conditions were taken and added to plates with incorporated M. luteus. It was 
incubated at 37°C for 24h. After that period, the presence or absence of one inhibition 
zone was evaluated. A 100µL aliquot of “fresh made” 25µM TBT in TSB plates as 
control of TBT effect on M. luteus was also applied in the plate. This assay was done on 
time 0, and after 6, 24, 30, 48 and 54h. 
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1. Membrane protein extraction from Aeromonas molluscorum Av27 
 
An identical quantity of protein per samples from the protocol 1 (32.5 µg) and 
protocol 2 (30.1 µg) was separated by SDS-PAGE.  
Analysis of the extracts from protocol 1, 15% SDS-PAGE showed weak 
resolution below the 20kDa zone (fig. 8). To solve this problem 20% SDS-PAGE were 
used instead, in which we could observe 13 bands with higher intensity in the 
TBT/Av27 sample when compared to 0/Av27 sample (fig. 8).  These 13 bands were 
individually excised from the gel and analyzed by MALDI-TOF; the full extracts were 
also analyzed. When performing the SDS-PAGE with the samples recovered from 
protocol 2 the resolution of the gel was weak. Thus it was decided to use Tricine SDS-
PAGE methodology, which allowed a better separation of the bands; from this gel, 8 
bands were excised and analyzed by MALDI-TOF. The full extracts were also analyzed.  
Fig. 9 - SDS-PAGE of the protein extracts from protocol 1 (B) and protocol 2 (A). White spots indicate 
bands excised for MS analysis. 0/Av27 - culture of Av27 without TBT; TBT/Av27 - culture of Av27 
with 500 µM of TBT; M - SDS-PAGE MW standards, low range (Bio-Rad).  
Fig. 8  - SDS-PAGE of the protein extracts from protocol 1 (B) and protocol 2 (A). White spots indicate 
bands excised (numerated bottom to top) for MS analysis. 0/Av27 - culture of Av27 without TBT; TBT/Av27 
- culture of Av27 with 500 µM of TBT; M - SDS-PAGE MW standards, low range (Bio-Rad). A - 20% 
polyacrylamide gel; B – 16% Tris-Tricine polyacrylamide gel.  
A B 
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As can be seen in the table 3.2 (Appendix 3) with the SDS-PAGE and MS analysis 
it can be suggested that proteins associated with the protein synthesis (e.g.: ribosomal 
proteins, elongation factors), transcription of DNA (e.g.: RNA polymerase) and 
glucolysis (e.g.: pyruvate dehydrogenase) are being over-expressed. These results 
seem feasible, since the cell has to cope possibly with TBT toxicity and therefore the 
expression of genes involved in translation and also in other metabolic basic functions 
of the cell increased.  Dubey et al. (2006) transcriptome analysis of the TBT-resistant P. 
aeruginosa 25W evidenced that transcriptional and translational genes are likely 
affected by TBT toxicity. Meanwhile, Fukushima et al. (2009) demonstrated by DNA 
microarray analysis in the same strain that downregulated genes were related with 
translational and energy metabolism, evidencing that these mechanisms are firstly 
affected. Also, TBT exposure leads to the upregulation of ribosomal protein gene, 
ribosome-modulation factor gene, elongation factor Tu gene and cold-shock protein 
gene. This indicates that in P. aeruginosa 25W, TBT affects initially a set of genes and 
the upregulation of some other genes enhances the translation machinery, 
maintaining the biosynthesis in the cell (Fukushima et al, 2009). Therefore it can be 
suggested that, A. molluscorum Av27 probably have the same resistance mechanism, 
since the same set of genes/proteins appears to be involved and over-expressed after 
TBT exposure. Nevertheless, to corroborate these findings DNA transcriptome and 
microarrays must be carried out for the determination of the down and up regulated 
genes implicated by TBT exposure in this strain.   
From the protocol 2 in one of the bands excised (2nd from the bottom, fig. 8A) 
above the 14 kDa, by MS analysis a fragment was identified that shows high homology 
with D-alanine-D-alanine ligase (Ddl). This Ddl is an essential enzyme that catalyses the 
ligation of D-Ala–D-Ala in the assembly of peptidoglycan precursors, involved in the 
cell wall organization (Wu et al, 2008). The analysis of the SDS-PAGE (fig. 8A) suggests 
that this enzyme, Ddl, is being overexpressed in response to TBT exposure. This 
indicates that the preservation and maintenance of the cell wall organization could be 
one of the TBT-resistance mechanisms. However complementary studies must be 
carried out to clarify this finding.  
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Using the protocols above referred it was not possible to identify the SugE-Av27 
protein in the present work, and to investigate its involvement in the TBT resistance in 
A. molluscorum Av27. Nevertheless, Jude et al. (2004) reported that a multidrug efflux 
pump cluster gene, TbtABM, is involved in the TBT-resistance in Pseudomonas stutzeri. 
SugE-Av27 protein being a member of the SMR family (Cruz et al, 2010) is a proton-
dependent multidrug efflux system (Paulsen et al, 1996b), thus it has high probability 
to be involved in TBT resistance in A. molluscorum Av27.   
Despite the optimization of the two protocols tested for the extraction of 
membrane proteins in E. coli, they were not adequate to the extraction of membrane 
proteins from A. molluscorum Av27. SugE is an integral membrane protein that could 
be difficult to isolate, since it is surrounded of the cell membrane, it will be necessary 
to optimize these protocols or to try another approaches for the extraction of this 
protein. Also, other more efficient detergents can be tested that might help to improve 
the solubilization of this protein. 
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2. Heterologous expression of SugE-Av27 protein 
 
To characterize the SugE-Av27 protein higher amounts of the pure protein are 
needed. The purified protein will help to clarify some aspects such as: What is the 
conformational stability of the protein under different conditions? How protein-
protein interactions and protein-ligand alters the conformation of the protein? How 
SugE is involved in the resistance of Aeromonas molluscorum Av27? Is it involved in 
other mechanisms of resistance?  
To that end, a vector with the gene sugE-Av27 was constructed. Two different 
constructs were made : i)  the gene sugE was inserted in the vector pET24 with the 
deletion of the stop codon, so that the protein will be linked to an his-tag; and ii)  the 
stop codon was kept in the sugE gene to be used in the Western Blot as a control.  
For the heterologous expression of SugE protein, sugE gene was inserted on 
pET24 in E. coli BL21 (DE3) with an his-tag. The tag will allow the purification of the 
heterologous protein by IMAC. The transformation was well succeeded in the two 
clones, and was confirmed with screening by colony PCR with the appropriate primers 
(T7prom and T7term), followed by nucleotide sequencing. 
  The transformation of E. coli BL21 (DE3) with the two different plasmids was 
well succeeded leading to three different clones, BL21 pET24_sugE_HT and BL21 
pET24_sugE_STOP.  
Proteins from the E. coli BL21 pET24_sugE_HT clone induced and uninduced 
with IPTG were analyzed by SDS-PAGE followed by Western Blot with anti-his-tag. The 
blot analysis revealed that, at 37°C, the highest expression of SugE protein occurs after 
4h of induction. This clone showed poor leaky expression in the cultures grown 
without IPTG when compared with the induced ones. 
The BL21 pET24_sugE_HT was used to the expression of SugE protein with IPTG 
induction and the western blot analyses showed that there is a high expression of this 
protein after an incubation period of 4h at 37°C, 180rpm with 1mM of IPTG. 
Nevertheless, other temperatures and IPTG concentrations must be tested in order to 
obtain maximum expression level.  
M 
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Fig. 9 - Autoradiography of the Western Blot analysis. White arrow indicates the 4h induction detection. 
M - Bio-Rad Precision Plus Protein dual color standards; A → (1) – negative control, pET24_SugE_STOP 
(2) – positive control, pETNEK (Wu et al, 2007) (3) – 1 mM IPTG/1h, (4) -  without IPTG/1h, (5) – 1 mM 
IPTG/2h, (6) -  without IPTG/2h; (B)  (1) – negative control, pET24_SugE_STOP, (2) – pETNEK (Wu et al, 
2007), (3) – 1 mM IPTG/3h, (4) -  without IPTG/3h, (5) – 1 mM IPTG/4h, (6)-  without IPTG/4h. 
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3. M. luteus: a bioindicator species for rapid TBT degradation/toxicity evaluation 
experiments  
 
With the test of sensitivity it was determined that M. luteus is sensible to any of 
the tested concentrations of TBT (25 µM, 50 µM and 100 µM) and is tolerant to 25 µM 
of DBT (fig. 10). Thus it can be used as an indicator specie to evaluate the presence of 
TBT in the culture medium, thus allowing to predict the degradation of TBT to DBT by 
Av27. 
In the degradation experiment, using the plate bioassay, it was observed that 
the inhibition zone in the wells containing the Av27’s culture disappear after 54h (fig. 
11). So it can be predicted that the toxicity of TBT has been decreased, probably due to 
the TBT degradation to DBT, since growth of M. luteus was observed around the well. 
A 
Fig. 10 - Plate assay testing the sensitivity of M. luteus (left in side of plate) and Av27 (right in side of 
the plate) to TBT and DBT. (A) TSA (B) TSA + 25µM TBT (C) TSA + 25µM DBT 
Fig. 11 - Plate assay for the degradation of TBT experiment. (A) Assay made at T0h (B) T24h (C) T54h; CT – 
25 µM TBT control; TBT – Av27 incubated with 25 µM TBT; Av27 – Av27 incubated without TBT. 
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These experiments need to be repeated and some parameters must be 
changed, for instance i) different culture media like Tryptic Soy Broth, Marine Broth 
and Minimal Medium, ii) addition of selected different nutrients and iii) variations of 
pH, salinity, temperature and bacterial cell density.  Furthermore, samples withdrawn 
from the liquid assays will be then sent to organotin content analyses by GC-MS in 
order to confirm and evaluate the TBT degradation. Those results are fundamental to 
prove the sensitivity of the method as well as to confirm its applicability as a rapid and 
feasible method to evaluate TBT degradation. 
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In the present work, one of the aims was to verify the over-expression of SugE 
protein, involved in the resistance to TBT in A. molluscorum Av27. This aim was not 
completely achieved. It seems that the protocols used for the membrane protein 
extraction were not effective for this strain or to extract the target protein being 
studied, since MS results revealed the presence mainly of cytoplasmic proteins in the 
protein extracts. However, several proteins involved in metabolic pathways essential 
for cell survival, such as glycolysis, ATP synthesis and protein biosynthesis could be 
identified. Additionally, a cell wall biosynthesis related protein, Ddl, is suggested to be 
over-expressed in this strain exposed to TBT. 
 
For the characterization of SugE protein, it is necessary to have this protein in 
high amounts and in its pure form. For this purpose, E. coli cells were transformed with 
the vector pET24 where the sugE gene was inserted. The fusion protein, SugE_his-tag 
protein, seems to have its highest production when the clone is incubated at 37°C, 
160rpm for 4h with 1mM of IPTG. Nevertheless, in future work other concentrations of 
IPTG and other incubation temperatures need to be tested in order to achieve the 
maximum expression of the fusion protein. 
 
Since organotin analysis is time consuming and associated with high costs, the 
use of M. luteus as an indicator specie to evaluate TBT degradation/toxicity seems to 
be a rapid, simple and useful method, prior to GS-MS analysis. After validation more 
tests, with the variation of physical and chemical parameters, can be performed in 
order to optimize the TBT degradation by A. molluscorum Av27.  
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This study provides the basis for future work with A. molluscorum Av27 and its 
application in bioremediation of TBT contaminated sites. Thus the following 
conclusions can be withdrawn: 
 
 Further studies are needed to better clarify the mechanisms behind TBT 
resistance in A. molluscorum Av27, namely those  that will evaluate the 
regulation of genes  expressed in response to TBT exposure; 
 
 Heterologous expression in an E. coli system, shows to be a suitable  
approach to express and purify SugE-Av27 protein, for further 
characterization; 
 
 The use of a bioassay based on M. luteus inhibition to evaluate TBT 
degradation by Av27, shows to be an efficient and rapid method, prior 
to GC-MS analysis.  
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G. Appendix 
  
  
 
Appendix 1 
 
Table 1.1 – Recipe of SDS-PAGE gels. 
1
stacking gel; 
2
running gel 
Reagents 
Stacking gel 
6% 
Running gel 
16% 
Running gel 
18% 
Running gel 
20% 
Bis-Acryl (30:0.8) 1 ml 8 ml 6 ml 5.33 ml 
0.5M1/3M2 Tris pH 8.01, 
pH 6.82 
1.25 ml 5 ml 1.25 ml 1 ml 
10% SDS 50 µl 150.5 µl 100 µl 80 µl 
MQH2O 2.616 ml - 2.58 ml 1.527 ml 
15% APS 34 µl 34 µl 50 µl 53 µl 
TEMED 5 µl 5 µl 20 µl 8 µl 
Urea - 5.4 g - - 
 
 
  
 
Appendix 2 
 
Table 2.1 - PCR primers sequences for the amplification of sugE-Av27 gene and for the screening of 
positive clones. The shadow zone in the sequence represents the enzyme restriction sites.  
.  
 
 
Table 2.2 - PCR program for the amplification of the sugE-Av27 gene (A); screening of positive clones (B); 
and (C) amplification with the T7term and T7prom primers. 
 
 A B C 
 Temperature Time Temperature Time Temperature Time 
Initial denaturation 95°C 5 min 95°C 5 min 95°C 5 min 
C
yc
le
 p
ro
gr
am
 :
 3
0
X
 Denaturation 95°C 30 s 95°C 30 s 95°C 30 s 
Annealing 54°C 30  s 54°C 30  s 52°C 30  s 
Extension 68°C 45 s 72°C 45 s 72°C 45 s 
Final extension 68°C 
10 
min 
72°C 
10 
min 
72°C 
10 
min 
 
 
 
 
 
Primer Sequence 
SugE_NdeI_fw 5’- AAGGAGATATACATATGTTCATGCCCTGGATATTGCTG-3’ 
SugE_XhoI_his_rv 5’- GGTGGTGGTGCTCGAGACCGATGGCTTTGAGACCCAG-3’ 
SugE_XhoI_rv 5’- GGTGGTGGTGCTCGAGTCAACCGATGGCTTTGAGACCCAG-3’ 
T7prom 5’ - GCTAGTTATTGCTCAGCG - 3’ 
T7term 5’ - TAATACGCATCACTATAGGG - 3’ 
  
 
Appendix 3 
 
 
 
Table 3.1 – List of proteins indentified in the extracts from Av27 grown in the presence of 500µM TBT. 
Red square indicates homologous proteins identified in the experiments of Dubey et al. (2006) and 
Fukushima et al. (2009)  
Protein Accession Nº MW (Da) Biologic process 
Protocol 1 
    
50S ribosomal protein L29 RL29_AERS4 7189,85 Protein biosynthesis  
30S ribosomal protein S20 RS20_AERSA 7967,41 Protein biosynthesis  
30S ribosomal protein S21 RS21_AERS4 8467,74 Protein biosynthesis  
DNA-binding protein HU-alpha DBHA_AERHY 9393,13 Protein biosynthesis  
30S ribosomal protein S19 RS19_AERS4 10433,74 Protein biosynthesis  
50S ribosomal protein L24 RL24_AERHH 11302,40 Protein biosynthesis  
50S ribosomal protein L21 RL21_AERHH 11392,11 Protein biosynthesis  
50S ribosomal protein L22 RL22_AERS4 12386,88 Protein biosynthesis  
50S ribosomal protein L19 RL19_AERS4 13156,27 Protein biosynthesis  
30S ribosomal protein S13 RS13_AERS4 13192,30 Protein biosynthesis  
50S ribosomal protein L14 RL14_AERS4 13394,29 Protein biosynthesis  
30S ribosomal protein S11 RS11_AERS4 13826,36 Protein biosynthesis  
30S ribosomal protein S9 RS9_AERS4 14759,98 Protein biosynthesis  
50S ribosomal protein L15 RL15_AERS4 15039,27 Protein biosynthesis  
30S ribosomal protein S6 RS6_AERS4 15067,42 Protein biosynthesis  
50S ribosomal protein L13 RL13_AERS4 15798,51 Protein biosynthesis  
  
 
30S ribosomal protein S5 RS5_AERS4 17328,29 Protein biosynthesis  
30S ribosomal protein S7 RS7_AERS4 17408,39 Protein biosynthesis  
50S ribosomal protein L6 RL6_AERHH 18511,03 Protein biosynthesis  
50S ribosomal protein L5 RL5_AERS4 20227,63 Protein biosynthesis  
50S ribosomal protein L4 RL4_AERHH 22182,91 Protein biosynthesis  
50S ribosomal protein L3 RL3_AERS4 22349,83 Protein biosynthesis  
30S ribosomal protein S4 RS4_AERS4 23378,50 Protein biosynthesis  
50S ribosomal protein L1 RL1_AERHH 24585,24 Protein biosynthesis  
30S ribosomal protein S3 RS3_AERHH 26117,20 Protein biosynthesis  
30S ribosomal protein S2 RS2_AERS4 26894,77 Protein biosynthesis  
50S ribosomal protein L2 RL2_AERS4 29974,11 Protein biosynthesis  
RNA polymerase subunit alpha RPOA_AERS4 36173,00 Transcription  
Elongation factor Tu EFTU_AERS4 43272,15 Protein biosynthesis  
Na(+)-NQR subunit F NQRF_VIBVY 44916,13 Sodium ion transport  
Enolase ENO_TOLAT 45525,47 Glycolysis  
ATP-binding subunit ClpX CLPX_AERS4 46434,22 Protein folding  
NAD(P) transhydrogenase subunit 
beta 
PNTB_ECOL6 48691,52 
 
ATP synthase subunit beta ATPB_ALTMD 49946,65 
ATP synthesis coupled 
proton transport 
Sulfate adenylyltransferase 
subunit 1 
CYSN_AERS4 52190,24 Sulfur metabolism  
ATP synthase subunit alpha ATPA_AERS4 55173,97 
ATP synthesis coupled 
proton transport 
phosphoglycerate mutase GPMI_AERS4 55240,39 Glycolysis  
60 kDa chaperonin - GroEL 
protein 
CH60_AERHH 57144,64 Protein refolding  
GMP synthase GUAA_AERS4 58475,62 Purine biosynthesis  
Chaperone protein dnaK DNAK_PROMH 69240,56 Stress response  
  
 
Chaperone protein htpG HTPG_AERS4 71684,29 Stress response  
Threonyl-tRNA synthetase SYT_AERS4 72869,54 Protein biosynthesis  
Polyribonucleotide 
nucleotidyltransferase 
PNP_AERS4 76394,63 
mRNA catabolic 
process  
Elongation factor G EFG_AERS4 77448,38 Protein biosynthesis  
Translation initiation factor IF-2 IF2_AERS4 98315,86 Protein biosynthesis  
RNA polymerase subunit beta RPOB_AERS4 150158,14 Transcription  
RNA polymerase subunit beta-
beta 
RPOBC_WOLTR 317901,84 Transcription  
    
Protocol 2 
    
Glyceraldehyde-3-phosphate 
dehydrogenase 
G3P1_SYNY3 36123,36 Glycolysis 
ATP synthase subunit alpha ATPA_AERS4 55173,97 ATP synthesis 
ATP synthase subunit beta ATPB_PSEA8 55211,82 ATP synthesis 
Chaperone protein dnaK 
DNAK_AERS
4 
69514,81 
Chaperones and heat 
shock proteins 
Translation initiation factor IF-2 IF2_AERHH 98109,74 Protein biosynthesis 
Pyruvate dehydrogenase E1 component ODP1_ECOLI 99605,95 Glycolysis  
Elongation factor Tu EFTU_AERS4 43272,15 Protein biosynthesis  
Elongation factor G EFG_AERS4 77448,38 Protein biosynthesis  
Elongation factor G EFG_PHOLL 77649,19 Protein biosynthesis  
Elongation factor Ts EFTS_AERS4 31140,09 Protein biosynthesis  
RNA polymerase subunit alpha RPOA_AERS4 36173,00 Transcription  
RNA polymerase subunit beta RPOC_AERS4 158099,48 Transcription  
50S ribosomal protein L34 RL34_AERS4 5046,91 Protein biosynthesis  
50S ribosomal protein L33 RL33_SACD2 5981,20 Protein biosynthesis  
  
 
50S ribosomal protein L32 RL32_AERS4 6212,28 Protein biosynthesis  
50S ribosomal protein L30 RL30_AERS4 6606,54 Protein biosynthesis  
50S ribosomal protein L29 RL29_AERS4 7189,85 Protein biosynthesis  
30S ribosomal protein S20 RS20_AERHY 7967,41 Protein biosynthesis  
30S ribosomal protein S21 RS21_AERS4 8467,74 Protein biosynthesis  
30S ribosomal protein S17 RS17_AERHH 9393,13 Protein biosynthesis  
30S ribosomal protein S15 RS15_AERS4 10076,47 Protein biosynthesis  
30S ribosomal protein S19 RS19_AERS4 10433,74 Protein biosynthesis  
50S ribosomal protein L24 RL24_AERS4 11292,31 Protein biosynthesis  
30S ribosomal protein S14 RS14_AERS4 11522,26 Protein biosynthesis  
50S ribosomal protein L22 RL22_AERS4 12386,88 Protein biosynthesis  
50S ribosomal protein L18 RL18_AERS4 12471,74 Protein biosynthesis  
50S ribosomal protein L19 RL19_AERS4 13156,27 Protein biosynthesis  
50S ribosomal protein L14 RL14_AERS4 13394,29 Protein biosynthesis  
50S ribosomal protein L20 RL20_AERS4 13417,60 Protein biosynthesis  
30S ribosomal protein S11 RS11_AERS4 13826,36 Protein biosynthesis  
30S ribosomal protein S8 RS8_AERS4 13992,52 Protein biosynthesis  
50S ribosomal protein L17 RL17_AERS4 14307,66 Protein biosynthesis  
30S ribosomal protein S9 RS9_AERS4 14759,98 Protein biosynthesis  
50S ribosomal protein L11 RL11_AERS4 14979,92 Protein biosynthesis  
50S ribosomal protein L15 RL15_AERS4 15039,27 Protein biosynthesis  
50S ribosomal protein L9 RL9_AERS4 15319,33 Protein biosynthesis  
50S ribosomal protein L16 RL16_AERHH 15372,32 Protein biosynthesis  
50S ribosomal protein L13 RL13_AERS4 15798,51 Protein biosynthesis  
  
 
30S ribosomal protein S5 RS5_AERS4 17328,29 Protein biosynthesis  
30S ribosomal protein S7 RS7_AERS4 17408,39 Protein biosynthesis  
50S ribosomal protein L10 RL10_AERS4 17699,43 Protein biosynthesis  
50S ribosomal protein L6 RL6_AERHH 18511,03 Protein biosynthesis  
50S ribosomal protein L5 RL5_AERS4 20227,63 Protein biosynthesis  
50S ribosomal protein L3 RL3_AERHH 22408,93 Protein biosynthesis  
30S ribosomal protein S4 RS4_AERS4 23378,50 Protein biosynthesis  
50S ribosomal protein L1 RL1_AERS4 24588,21 Protein biosynthesis  
30S ribosomal protein S3 RS3_AERHH 26117,20 Protein biosynthesis  
30S ribosomal protein S2 RS2_AERS4 26894,77 Protein biosynthesis  
50S ribosomal protein L2 RL2_AERS4 29974,11 Protein biosynthesis  
 
 
Table 3.2 - List of proteins identified in the bands excised from SDS-PAGE analysis. Red square indicates 
homologous proteins identified in the experiments of Dubey et al. (2006) and/or Fukushima et al. 
(2009). Bands were numbered from bottom to top.  
Band Nº Protein Accession Nº MW (Da) Pathway 
Protocol 1 
     
1 50S ribosomal protein L29 RL29_AERS4 7189,9 Protein Biosynthesis 
3 50S ribosomal protein L28 RL28_AERHH 8848,8 Protein Biosynthesis 
4 50S ribosomal protein L27 RL27_AERS4 9061,9 Protein Biosynthesis 
5 50S ribosomal protein L19 RL19_AERS4 13156,3 Protein Biosynthesis 
6 30S ribosomal protein S11 RS11_AERS4 13826,4 Protein Biosynthesis 
7 50S ribosomal protein L16 RL16_AERS4 15386,3 Protein Biosynthesis 
  
 
8 50S ribosomal protein L13 RL13_AERS4 15798,5 Protein Biosynthesis 
8 30S ribosomal protein S5 RS5_AERS4 17328,3 Protein Biosynthesis 
9 50S ribosomal protein L4 RL4_AERS4 22196,9 Protein Biosynthesis 
10 50S ribosomal protein L3 RL3_AERS4 22349,8 Protein Biosynthesis 
10 30S ribosomal protein S4 RS4_AERS4 23378,5 Protein Biosynthesis 
11 50S ribosomal protein L2 RL2_AERS4 29974,1 Protein Biosynthesis 
12 
DNA-directed RNA 
polymerase subunit alpha 
RPOA_AERS4 36173,0 Transcription 
     
Protocol 2 
     
2 D-alanine-D-alanine ligase DDL_AERHH 36320,5 
Cellular cell wall 
organization  
3 Peptide chain release factor 1 RF1_ZYMMO 39296,2 Protein Biosynthesis 
5 30S ribosomal protein S8 RS8_AERS4 13992,5 Protein biosynthesis  
5 30S ribosomal protein S14 RS14_AERS4 11522,3 Protein biosynthesis  
6 Elongation factor Tu EFTU_AERS4 43272,1 Protein Biosynthesis 
7 
RNA polymerase subunit 
alpha 
RPOA_AERS4 36173 Transcription 
7 Phosphoglycerate kinase PGK_AERS4 40439,1 Glycolysis 
 
 
 
 
